CLVT - Clarivate Plc

Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member

Veteran Insurance Executive Brings Carrier Relationships and Data Analytics Expertise  to Support Accuserve's Continued Growth and Its Mission to Simplify the Claims Experience DENVER, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Accuserve Solutions (“Accuserve” or the “Company”), an independent managed repair services platform connecting insurance carriers, homeowners, and contractors, today announced the appointment of Maroun S.

Sep 01, 2026 05:00 AM • globenewswire.com

Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

Cornick's purchase increased his total holdings by 74% despite stock declining 52% over the past year, signaling conviction in the company's recovery prospects.

Aug 18, 2026 02:31 PM • fool.com

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycle LONDON, Aug. 6, 2026 /PRNewswire/ --  Clarivate Plc  (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the expansion of agentic AI capabilities across the Cortellis portfolio, helping life sciences R&D teams accelerate discovery, strengthen safety assessment and make faster, more informed portfolio decisions. By embedding AI directly within existing workflows, the new capabilities enable researchers to reduce manual effort, navigate complexity and focus on higher-value scientific and strategic decisions.

Aug 06, 2026 12:00 AM • prnewswire.com

First Trust Advisors LP Has $13.97 Million Stock Holdings in Clarivate PLC $CLVT

First Trust Advisors LP lifted its stake in shares of Clarivate PLC (NYSE: CLVT) by 10.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,522,601 shares of the company's stock after acquiring an additional 516,418 shares during the quarter.

Jul 31, 2026 12:47 AM • defenseworld.net

Clarivate Q2 Earnings Call Highlights

Clarivate NYSE: CLVT said during its earnings call that it expects organic recurring revenue and annualized contract value growth to improve in the second half of the year, citing renewal visibility, product momentum and a growing pipeline of AI-enabled offerings.

Jul 29, 2026 12:04 PM • marketbeat.com

Clarivate Plc (CLVT) Q2 2026 Earnings Call Transcript

Clarivate Plc (CLVT) Q2 2026 Earnings Call Transcript

Jul 29, 2026 08:13 AM • seekingalpha.com

Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Clarivate (CLVT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Jul 29, 2026 06:31 AM • zacks.com

Clarivate PLC (CLVT) Q2 Earnings and Revenues Beat Estimates

Clarivate PLC (CLVT) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago.

Jul 29, 2026 04:31 AM • zacks.com

Clarivate Appoints Michael Easton as Chief Financial Officer

Experienced Clarivate leader brings more than 25 years of financial and operational expertise LONDON, July 29, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today announced the appointment of Michael Easton as Executive Vice President and Chief Financial Officer, effective August 8, 2026. He succeeds Jonathan Collins who is stepping down as CFO to pursue another opportunity.

Jul 29, 2026 02:05 AM • prnewswire.com

Clarivate Reports Second Quarter 2026 Results

— Delivers continued progress on strategic and financial priorities through Value Creation Plan —— Sharpens focus and enhances financial profile with previously announced Life Sciences & Healthcare segment divestiture —— Reaffirms 2026 financial outlook — LONDON, July 29, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 2026. Executive Commentary Matti Shem Tov, Chief Executive Officer: "The Value Creation Plan continues to drive meaningful progress, as we execute against our strategic priorities and strengthen Clarivate's foundation for organic growth acceleration.

Jul 29, 2026 02:00 AM • prnewswire.com

Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers

Prestigious awards program recognizes innovative AI technology transforming trademark risk assessment for legal professionals LONDON, July 20, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that RiskMark has been named the winner of the 2026 CODiE Award for Best AI Tool for Lawyers. The award recognizes AI-driven solutions that significantly enhance the efficiency, accuracy and capabilities of legal professionals through advanced technology.

Jul 19, 2026 11:00 PM • prnewswire.com

USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate

LONDON, July 16, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, is proud to support the U.S. Patent and Trademark Office (USPTO) in launching an AI assisted image search within its public trademark search system, TM Search. This new capability allows users to upload and compare images against the U.S. trademark register and has been selected and awarded a contract by the USPTO.

Jul 15, 2026 11:00 PM • prnewswire.com

Clarivate Selected by Abes to Modernize French National Academic Library System

New cloud-based, shared and scalable platform based on Alma, Primo and Rapido creates a unified library experience Library services, resource sharing and AI-powered discovery in one platform LONDON, July 14, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today that the Bibliographic Agency for Higher Education (Abes) has selected the company to modernize France's national academic library system, under a multi-year agreement. Abes supports higher education and research institutions across France with a documentation system including shared library data and services.

Jul 13, 2026 11:02 PM • prnewswire.com

Clarivate to Sell Life Sciences Unit to Altaris for $600M, Refocus Core Business

Clarivate NYSE: CLVT said it has reached an agreement to sell substantially all of its Life Sciences & Healthcare segment to Altaris, an investment firm focused on the healthcare industry, in a transaction valued at $600 million.

Jul 11, 2026 09:02 PM • marketbeat.com

Clarivate to Report Second Quarter 2026 Results on July 29, 2026

LONDON, July 10, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the second quarter 2026 before the market opens on Wednesday, July 29, 2026. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.

Jul 10, 2026 04:00 AM • prnewswire.com

Clarivate Plc (CLVT) M&A Call Transcript

Clarivate Plc (CLVT) M&A Call Transcript

Jul 06, 2026 08:02 AM • seekingalpha.com

Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million

Transaction sharpens company's focus on AI-driven transformative intelligence for its leading Academia & Government and Intellectual Property segments Enhances financial profile by improving revenue mix, expanding Adjusted EBITDA margin and lowering capital intensity; proceeds to be used to reduce debt Reaffirms full-year 2026 financial outlook Conference call and webcast scheduled for 9:00 AM eastern time LONDON, July 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today announced it has entered into a definitive agreement to divest its Life Sciences & Healthcare ("LS&H") segment to Altaris LLC, an investment firm with an exclusive focus on acquiring and building companies in the healthcare industry, for $600 million. Following the close of the transaction, Clarivate will be a subscription-first global provider of intelligence solutions, workflow software and tech-enabled services for its leading Academia & Government ("A&G") and Intellectual Property ("IP") segments.

Jul 06, 2026 02:00 AM • prnewswire.com

Clarivate Releases 2025 Sustainability Report

New report highlights progress against goals and a decline in total carbon emissions LONDON, June 23, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released its 2025 Sustainability Report, highlighting continued progress against its sustainability goals, including reduction of total reported greenhouse gas emissions by 24%. Clarivate partners with 45,000 organizations worldwide, including universities, research institutions, corporations, law firms, government agencies and life science and healthcare companies to address global challenges.

Jun 22, 2026 11:00 PM • prnewswire.com

Clarivate Releases Journal Citation Reports 2026

Clarivate Releases Journal Citation Reports 2026 PR Newswire LONDON, June 17, 2026

Jun 17, 2026 12:00 AM • gurufocus.com

Clarivate Releases Journal Citation Reports 2026

Advancing transparency and responsible journal evaluation LONDON, June 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the release of the Journal Citation Reports 2026. Now in its sixth decade, Journal Citation Reports (JCR) continues to provide a publisher-neutral framework for assessing journal influence across the global research ecosystem.

Jun 16, 2026 11:00 PM • prnewswire.com

Clarivate price target lowered to $2 from $2.50 at Barclays

$2.00 (was $2.15)

Manav Patnaik · Barclays

Jul 30, 2026 05:03 AM • TheFly

Clarivate price target raised to $2.50 from $2.40 at Barclays

$2.50 (was $2.44)

Manav Patnaik · Barclays

Jul 07, 2026 07:46 AM • TheFly

Clarivate downgraded to Neutral from Buy at Goldman Sachs

$3.60 (was $3.36)

Goldman Sachs

Jan 08, 2026 04:24 AM • TheFly

Clarivate downgraded to Underweight from Equal Weight at Morgan Stanley

$3.00 (was $3.57)

Morgan Stanley

Dec 17, 2025 05:04 AM • TheFly

Clarivate price target lowered to $4.20 from $4.80 at Goldman Sachs

$4.20 (was $3.35)

Goldman Sachs

Oct 30, 2025 07:35 AM • TheFly

Clarivate Is Oversold Stock Brimming with Turnaround Potential, Analyst Predicts

$11.00 (was $8.98)

Owen Lau · Oppenheimer

Jun 13, 2023 10:34 AM • Benzinga

Morgan Stanley Downgrades Clarivate to Equal-Weight, Raises Price Target to $12

$12.00 (was $11.19)

Morgan Stanley

Feb 06, 2023 12:48 AM • Benzinga

Goldman Sachs Maintains Buy on Clarivate, Lowers Price Target to $20

$20.00 (was $17.07)

Goldman Sachs

Apr 19, 2022 06:05 AM • Benzinga